The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer

Abstract Background Apatinib is an oral small‐molecule tyrosine kinase inhibitor that blocks vascular endothelial growth factor receptor‐2. Oral vinorelbine is a semisynthetic chemotherapeutic agent of vinorelbine alkaloids. Apatinib and oral vinorelbine have been proved to be effective in the treat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jia‐Yi Huang, Xue‐Lian Chen, Xiao‐Feng Xie, Lin Song, Li‐Ping Chen, Xiao‐Feng Lan, Xue Bai, Xiao Chen, Cai‐Wen Du
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-04-01
coleção:	Cancer Medicine
Assuntos:	antiangiogenesis therapy low‐dose apatinib metastatic breast cancer oral vinorelbine
Acesso em linha:	https://doi.org/10.1002/cam4.7181
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!